Genetic Suppression of SMN Mutations in Spinal Muscular Atrophy

脊髓性肌萎缩症中 SMN 突变的基因抑制

基本信息

批准号：
10280776
负责人：
ARTHUR H. M. BURGHES
金额：
$ 53.6万
依托单位：
OHIO STATE UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2021
资助国家：
美国
起止时间：
2021-07-01 至 2026-06-30
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10280776
关键词：
Address Affect Alleles Animals Axon Binding Biochemical Biochemical Pathway Biological Assay Birth C-terminal Cell Culture Techniques Cell Line Cell Survival Cells Clustered Regularly Interspaced Short Palindromic Repeats Complement Critical Pathways DNA Sequence Alteration Defect Development Disease Electrophysiology (science)Engineering Excision Exons Genes Genetic Genetic Suppression Human Lead Length Missense Mutation Modeling Motor Mus Mutate Mutation N-terminal Neuromuscular Diseases Pathogenesis Pathway interactions Patients Phenotype Plant Roots Proteins RNA RNA Splicing Reporting Role SMN deficiency SMN protein (spinal muscular atrophy)SMN1 gene SMN2 gene Small Nuclear Ribonucleoproteins Spinal Muscular Atrophy Study models System Tertiary Protein Structure Testing Transgenic Mice Translating Translations U7 Small Nuclear Ribonucleoprotein Zebrafish effective therapy loss of function motor neuron function mouse model mutant nervous system disorder overexpression profilin snRNP Biogenesis survival motor neuron gene

项目摘要

Spinal Muscular Atrophy is a devastating neuromuscular disease caused by insufficient amounts of SMN protein. SMA is caused by loss or mutation of the SMN1 gene and retention of the SMN2 gene. The SMN2 gene is a modifier of phenotype where milder SMA cases having more copies of SMN2. Rarely SMA patients have a missense mutation in the SMN1 gene. We can use these mutations and the protein domains they disrupt to study the function of the SMN protein. We have shown that SMA missense mutations are not functional by themselves but can function in the presence of some full-length wild-type SMN protein. Furthermore, we have shown that N and C-terminal SMN missense mutations can complement each other and rescue snRNP assembly in the complete absence of full-length wild-type SMN protein in mice. We have developed cell line that conditionally removes functional SMN to allow us test SMN missense mutations in culture. We have also used this cell line to test for suppressors of the SMNE134K mutation. We have identified a suppressor in the SmF protein that fully restores snRNP assembly lost due to the SMN E134K mutation. We now have a system to screen for suppressors of SMN missense mutations. In this proposal we will test the SmF suppressor we have found in two different SMN E134K mouse models and determine if this mutation rescues the SMA phenotype and survival of the SMA mouse. Thus, we can study the separate functions of SMN in snRNP assembly from the function of SMN in the axon. We will screen for additional suppressors using other SMN patient derived mutations to test other functional domains of SMN. We will investigate the role of SMN in the axon independent of Sm assembly by introducing HuD and truncated forms of SMN into the SMA mice via scAAV9. We have shown in cells that Smn exon2B is not required for cell survival. We will test scAAV9-Smn∆2 in SMA mice to confirm this finding and rescue the SMA phenotype. Finally we will test the role of profilin in axonal function in the SMA mouse using the SMNS230L mutation. Using genetic mutations we can dissect the functions of SMN in splicing and in the axon to resolve the underlying mechanism by which reduced SMN protein causes SMA.

脊柱肌肉萎缩是由不足量的SMN蛋白引起的毁灭性神经肌肉疾病。 SMA是由SMN1基因的丢失或突变引起的，并保留了SMN2基因。 SMN2基因是一个表型的修饰符，其中Miller SMA病例具有更多的SMN2副本。 SMA患者很少有 SMN1基因中的错义突变。我们可以使用这些突变和蛋白质域，它们中断研究SMN蛋白的功能。我们已经表明，SMA错义突变不起作用本身，但可以在某些全长野生型SMN蛋白的情况下起作用。此外，我们还有表明N和C末端SMN错义突变可以彼此完成并挽救SNRNP组件在完全没有小鼠中全长野生型SMN蛋白的情况下。我们已经开发了细胞系有条件地删除功能性SMN，以使我们在培养中测试SMN错义突变。我们也曾使用过该细胞系用于测试SMNE134K突变的补充。我们已经确定了SMF中的抑制器由于SMN E134K突变而完全恢复SNRNP组件的蛋白质。我们现在有一个系统筛选SMN错义突变的补充。在此提案中，我们将测试我们拥有的SMF抑制器在两个不同的SMN E134K小鼠模型中发现，并确定该突变是否反应SMA表型和SMA小鼠的生存。那就是我们可以从SNRNP组装中研究SMN的单独功能轴突中SMN的功能。我们将使用其他SMN患者筛选其他补充剂筛选测试SMN其他功能域的突变。我们将研究SMN在轴突独立中的作用通过SCAAV9将HUD和SMN的截断形式引入SMN的形式，通过SM组装。我们有在细胞中显示SMN Exon2b不需要细胞存活。我们将在SMA小鼠中测试SCAAV9-SMNΔ2 确认这一发现并营救SMA表型。最后，我们将测试profilin在轴突功能中的作用使用SMNS230L突变的SMA小鼠。使用基因突变，我们可以剖析SMN的功能在剪接和轴突中，以解决减少SMN蛋白会导致SMA的基本机制。